Literature DB >> 21323514

Genetic alterations in Sezary syndrome.

Katarzyna Iżykowska1, Grzegorz K Przybylski.   

Abstract

Sezary syndrome (SS) is a rare form of cutaneous T-cell lymphoma characterized by erythroderma and the presence of Sezary cells in the skin, lymph nodes, and peripheral blood. Over the past few decades, cytogenetic and molecular cytogenetic findings have revealed many genetic alterations in patients with SS. The most frequent genetic lesions include monosomy 10, losses of 10q and 17p, gains of 8q24 and 17q, and diverse structural alterations involving these regions. Expression patterns in regions of genomic imbalance show that a large number of genes in SS are deregulated, and this might have a causative role in oncogenesis. Overall, chromosomal instability is characteristic of this lymphoma and related to a poor prognosis, but no specific abnormalities that may be directly involved in development of the disease have yet been found.

Entities:  

Mesh:

Year:  2011        PMID: 21323514     DOI: 10.3109/10428194.2010.551159

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

Review 1.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

Review 2.  Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome.

Authors:  Cristina Cristofoletti; Antonella Bresin; Martina Fioretti; Giandomenico Russo; Maria Grazia Narducci
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

3.  A study of meiomitosis and novel pathways of genomic instability in cutaneous T-cell lymphomas (CTCL).

Authors:  Matthew Tsang; Jennifer Gantchev; Elena Netchiporouk; Linda Moreau; Feras M Ghazawi; Steven Glassman; Denis Sasseville; Ivan V Litvinov
Journal:  Oncotarget       Date:  2018-12-28

4.  Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures.

Authors:  Alberto Herrera; Anthony Cheng; Eleni P Mimitou; Angelina Seffens; Dean George; Michal Bar-Natan; Adriana Heguy; Kelly V Ruggles; Jose U Scher; Kenneth Hymes; Jo-Ann Latkowski; Niels Ødum; Marshall E Kadin; Zhengqing Ouyang; Larisa J Geskin; Peter Smibert; Terkild B Buus; Sergei B Koralov
Journal:  Blood       Date:  2021-10-21       Impact factor: 25.476

5.  Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome.

Authors:  Mark J Kiel; Anagh A Sahasrabuddhe; Delphine C M Rolland; Thirunavukkarasu Velusamy; Fuzon Chung; Matthew Schaller; Nathanael G Bailey; Bryan L Betz; Roberto N Miranda; Pierluigi Porcu; John C Byrd; L Jeffrey Medeiros; Steven L Kunkel; David W Bahler; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  Nat Commun       Date:  2015-09-29       Impact factor: 14.919

6.  Double-positive CD4 and CD8 Sézary syndrome.

Authors:  Denis Miyashiro; Marina Passos Torrealba; Kelly Cristina Manfrere; Juliana Pereira; Maria Notomi Sato; José Antonio Sanches
Journal:  JAAD Case Rep       Date:  2017-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.